Application of MR-ProADM to predict prevention of hospitalisation, derived from a multi-centre study.
作者信息
Cullinan Milo, Graziadio Sara, Price David Ashley
机构信息
Laboratory Medicine, Newcastle-upon-Tyne Hospitals Foundation Trust, Queen Victoria Road, Newcastle-upon-Tyne, NE1 4LP, UK.
NIHR Newcastle In Vitro Diagnostics Co-operative, Newcastle-upon-Tyne Hospitals Foundation Trust, Queen Victoria Road, Newcastle-upon-Tyne, NE1 4LP, UK.
出版信息
Crit Care. 2019 Apr 17;23(1):129. doi: 10.1186/s13054-019-2402-0.
Abstract
摘要
相似文献
1
Application of MR-ProADM to predict prevention of hospitalisation, derived from a multi-centre study.MR-ProADM在预测住院预防方面的应用，源自一项多中心研究。
Crit Care. 2019 Apr 17;23(1):129. doi: 10.1186/s13054-019-2402-0.
2
The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study.疑似感染患者就诊于急诊科时疾病进展的早期识别：一项多中心推导和验证研究。
Crit Care. 2019 Feb 8;23(1):40. doi: 10.1186/s13054-019-2329-5.
3
Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.呼吸困难患者入院时和住院期间降钙素原和中肾上腺髓质素检测的 30 天和 90 天死亡率预测价值。来自 VERyfing DYspnea 试验的结果。
Am J Emerg Med. 2014 Apr;32(4):334-41. doi: 10.1016/j.ajem.2013.12.045. Epub 2014 Jan 3.
4
Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.急性呼吸困难患者的中段肾上腺髓质素前体：来自阿克什胡斯心脏检查（ACE）2研究的数据。
Clin Biochem. 2017 May;50(7-8):394-400. doi: 10.1016/j.clinbiochem.2016.12.010. Epub 2017 Jan 5.
5
Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients.早期评估急性胸痛患者时的中段促肾上腺髓质素。
Int J Cardiol. 2013 Sep 30;168(2):1048-55. doi: 10.1016/j.ijcard.2012.10.025. Epub 2012 Nov 27.
6
Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome.中肾上腺髓质素作为儿童直立性心动过速综合征对盐酸米多君治疗反应的预测因子。
J Am Coll Cardiol. 2012 Jul 24;60(4):315-20. doi: 10.1016/j.jacc.2012.04.025.
7
MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.急诊科急性呼吸困难患者的中段心房利钠肽前体、中段肾上腺髓质素前体及降钙素原
Lung. 2016 Apr;194(2):185-91. doi: 10.1007/s00408-015-9837-0. Epub 2016 Jan 9.
8
Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD.血浆前肾上腺髓质素而非血浆前内皮素可预测慢性阻塞性肺疾病急性加重期的生存率。
Chest. 2008 Aug;134(2):263-272. doi: 10.1378/chest.08-0047. Epub 2008 May 19.
9
Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.中肾肽原作为脓毒症患者器官损伤标志物和死亡预测因子的作用。
J Infect. 2018 Mar;76(3):249-257. doi: 10.1016/j.jinf.2017.12.003. Epub 2017 Dec 12.
10
Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial.中段前肾上腺髓质素可预测胸痛患者的死亡率和主要不良心脏事件：CHOPIN试验结果
Acad Emerg Med. 2015 May;22(5):554-63. doi: 10.1111/acem.12649. Epub 2015 Apr 23.
本文引用的文献
1
Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study.中肾肽（MR-proADM）能否提高 NEWS 在预测轻度至中度疾病入院患者病情恶化方面的预后准确性？一项前瞻性单中心观察研究。
BMJ Open. 2019 Feb 22;8(11):e020337. doi: 10.1136/bmjopen-2017-020337.
2
The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study.疑似感染患者就诊于急诊科时疾病进展的早期识别：一项多中心推导和验证研究。
Crit Care. 2019 Feb 8;23(1):40. doi: 10.1186/s13054-019-2329-5.
Zotero 插件